Determinants of a Low CD4/CD8 Ratio in HIV-1–Infected Individuals Despite Long-term Viral Suppression
出版年份 2016 全文链接
标题
Determinants of a Low CD4/CD8 Ratio in HIV-1–Infected Individuals Despite Long-term Viral Suppression
作者
关键词
-
出版物
CLINICAL INFECTIOUS DISEASES
Volume 62, Issue 10, Pages 1297-1303
出版商
Oxford University Press (OUP)
发表日期
2016-02-16
DOI
10.1093/cid/ciw076
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Residual immune activation in combined antiretroviral therapy-treated patients with maximally suppressed viremia
- (2016) Amélie Guihot et al. AIDS
- CD8 T-Cell Expansion and Inflammation Linked to CMV Coinfection in ART-treated HIV Infection
- (2015) Michael L. Freeman et al. CLINICAL INFECTIOUS DISEASES
- Changes in Inflammation and Immune Activation With Atazanavir-, Raltegravir-, Darunavir-Based Initial Antiviral Therapy: ACTG 5260s
- (2015) Theodoros Kelesidis et al. CLINICAL INFECTIOUS DISEASES
- CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: an observational cohort study
- (2015) Cristina Mussini et al. Lancet HIV
- Immune resilience in HIV-infected individuals seronegative for cytomegalovirus
- (2014) Lisa Barrett et al. AIDS
- Significant Reduction in HIV Virologic Failure During a 15-Year Period in a Setting With Free Healthcare Access
- (2014) C. Delaugerre et al. CLINICAL INFECTIOUS DISEASES
- Factors Associated With CD8+ T-Cell Activation in HIV-1–Infected Patients on Long-term Antiretroviral Therapy
- (2014) Lu Zheng et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Multiparametric Bioinformatics Distinguish the CD4/CD8 Ratio as a Suitable Laboratory Predictor of Combined T Cell Pathogenesis in HIV Infection
- (2014) M. Buggert et al. JOURNAL OF IMMUNOLOGY
- Cytomegalovirus Coinfection Is Associated With an Increased Risk of Severe Non–AIDS-Defining Events in a Large Cohort of HIV-Infected Patients
- (2014) Miriam Lichtner et al. JOURNAL OF INFECTIOUS DISEASES
- Letermovir for Cytomegalovirus Prophylaxis in Hematopoietic-Cell Transplantation
- (2014) Roy F. Chemaly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Increased Risk of Serious Non-AIDS-Related Events in HIV-Infected Subjects on Antiretroviral Therapy Associated with a Low CD4/CD8 Ratio
- (2014) Sergio Serrano-Villar et al. PLoS One
- Tobacco Smoking Increases Immune Activation and Impairs T-Cell Function in HIV Infected Patients on Antiretrovirals: A Cross-Sectional Pilot Study
- (2014) Ranjini Valiathan et al. PLoS One
- HIV-Infected Individuals with Low CD4/CD8 Ratio despite Effective Antiretroviral Therapy Exhibit Altered T Cell Subsets, Heightened CD8+ T Cell Activation, and Increased Risk of Non-AIDS Morbidity and Mortality
- (2014) Sergio Serrano-Villar et al. PLoS Pathogens
- Severity of Cardiovascular Disease Outcomes Among Patients With HIV Is Related to Markers of Inflammation and Coagulation
- (2014) Anna D. Nordell et al. Journal of the American Heart Association
- The CD4/CD8 ratio as a marker T-cell activation, senescence and activation/exhaustion in treated HIV-infected children and young adults
- (2013) Talía Sainz et al. AIDS
- The CD4:CD8 ratio is associated with markers of age-associated disease in virally suppressed HIV-infected patients with immunological recovery
- (2013) S Serrano-Villar et al. HIV MEDICINE
- Associations of Inflammatory Markers With AIDS and Non-AIDS Clinical Events After Initiation of Antiretroviral Therapy
- (2013) Grace A. McComsey et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Predictors of CD4:CD8 Ratio Normalization and Its Effect on Health Outcomes in the Era of Combination Antiretroviral Therapy
- (2013) Victor Leung et al. PLoS One
- The inverted CD4/CD8 ratio and associated parameters in 66-year-old individuals: the Swedish HEXA immune study
- (2012) J. Strindhall et al. AGE
- Circulating interleukin-6 levels correlate with residual HIV viraemia and markers of immune dysfunction in treatment-controlled HIV-infected patients
- (2012) Jean-Philippe Bastard et al. ANTIVIRAL THERAPY
- Higher Immunoglobulin G Antibody Levels Against Cytomegalovirus Are Associated With Incident Ischemic Heart Disease in the Population-Based EPIC-Norfolk Cohort
- (2012) E. Gkrania-Klotsas et al. JOURNAL OF INFECTIOUS DISEASES
- Cytomegalovirus and Immunological Aging: The Real Driver of HIV and Heart Disease?
- (2012) A. E. Aiello et al. JOURNAL OF INFECTIOUS DISEASES
- T-Cell Phenotypes, Apoptosis and Inflammation in HIV+ Patients on Virologically Effective cART with Early Atherosclerosis
- (2012) Esther Merlini et al. PLoS One
- HIV disease progression despite suppression of viral replication is associated with exhaustion of lymphopoiesis
- (2011) D. Sauce et al. BLOOD
- Valganciclovir Reduces T Cell Activation in HIV-Infected Individuals With Incomplete CD4+ T Cell Recovery on Antiretroviral Therapy
- (2011) Peter W. Hunt et al. JOURNAL OF INFECTIOUS DISEASES
- Clinical Predictors of Immune Reconstitution following Combination Antiretroviral Therapy in Patients from the Australian HIV Observational Database
- (2011) Reena Rajasuriar et al. PLoS One
- Immune reconstitution after a decade of combined antiretroviral therapies for human immunodeficiency virus
- (2011) Amélie Guihot et al. TRENDS IN IMMUNOLOGY
- Immune and virological benefits of 10 years of permanent viral control with antiretroviral therapy
- (2010) Amélie Guihot et al. AIDS
- Increased prevalence of subclinical coronary atherosclerosis detected by coronary computed tomography angiography in HIV-infected men
- (2009) Janet Lo et al. AIDS
- Poor Baseline Immune Function Predicts an Incomplete Immune Response to Combination Antiretroviral Treatment Despite Sustained Viral Suppression
- (2009) Kathleen Falster et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- The immune risk profile is associated with age and gender: findings from three Swedish population studies of individuals 20–100 years of age
- (2008) Anders Wikby et al. BIOGERONTOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started